Navigation Links
Immunosyn Announces the Successful Completion of First Phase 'Proof of Concept Trial' in Europe for Treatment of Diabetic Ulcers With Biopharmeceutical SF-1019
Date:1/17/2008

e. Research suggests that SF-1019 has the potential to affect a number of clinical conditions including complications from Diabetic Mellitus such as Diabetic Neuropathy (DN) and diabetic ulcers (DU), auto-immune disorders such as Multiple Sclerosis (MS) and neurological disorders such as Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and Reflex Sympathetic Dystrophy Syndrome (RSD or RSDS). (For more information on Immunosyn and SF-1019 go to http://www.immunosyn.com)

The above news release contains forward-looking statements. These statements are based on assumptions that management believes are reasonable based on currently available information, and include statements regarding the intent, belief or current expectations of the Company and its management. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance, and are subject to a wide range of business risks, external factors and uncertainties. Actual results may differ materially from those indicated by such forward-looking statements. For additional information, please consult the Company's most recent public filings and Annual Report on Form 10-K for its most recent fiscal year. The Company assumes no obligation to update the information contained in this press release, whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE Immunosyn Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Immunosyn Corporation Names Stephen Ferrone as CEO
2. Immunosyn Corporation to Begin Trading
3. Equity Research Firm Issued Unauthorized Report and Press Release on Immunosyn Corporation Today
4. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
5. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
6. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
7. HEI, Inc. Announces Sale of RFID Division Assets
8. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
9. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
10. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
11. Brooke Franchise Corporation Announces Selected July Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... (PRWEB) September 02, 2014 Alliance Strategies ... and multi-channel email marketing is pleased to announce it ... Firearms & Freedom as well as ... represent more than one million concerned Americans who can ... , “We are honored to continue providing our ...
(Date:9/2/2014)... New research shows a novel polypill increases patient ... or heart attack, according to new study results ... Congress 2014 in Barcelona, Spain. According to Principal ... Sinai Heart at Icahn School of Medicine at ... Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) in ...
(Date:9/2/2014)... at the University of California, San Diego School of ... of breast cancer. The findings, reported in the ... cause of breast cancer mortality worldwide. An estimated 40,000 ... 2014, according to the American Cancer Society. , "The ... found a way to target breast cancer metastasis through ...
(Date:9/2/2014)... Obesity is associated with many health risks, including heart ... found a possible way to mitigate one often-overlooked risk: ... study led by Sheldon H. Jacobson, a professor of ... obesity rates are associated with a decrease in seatbelt ... laws are in effect. , "Primary seatbelt laws lead ...
(Date:9/2/2014)... York, NY (PRWEB) September 02, 2014 ... Jackman Foundation (BJF), a children’s literacy organization that has ... in need since its founding in 2001, will host ... from 1 – 2:30 p.m. at Barnes & Noble ... Daniel Nigro, this free public event for children and ...
Breaking Medicine News(10 mins):Health News:ASG Continues to Bring New Lists to Market 2Health News:ASG Continues to Bring New Lists to Market 3Health News:New polypill increases heart attack patients' medication adherence 2Health News:New polypill increases heart attack patients' medication adherence 3Health News:Enzyme controlling metastasis of breast cancer identified 2Health News:Seatbelt laws encourage obese drivers to buckle up 2Health News:Brooke Jackman Foundation Hosts 5th Annual Read-A-Thon, A Celebration of Hope and Literacy in New York City to Commemorate 13th Anniversary of 9/11 2Health News:Brooke Jackman Foundation Hosts 5th Annual Read-A-Thon, A Celebration of Hope and Literacy in New York City to Commemorate 13th Anniversary of 9/11 3
... was on his way to becoming a lawyer says how a ... ice, and I went straight over backwards," he says. "I wasn’t ... blood coming out of my ears and my nose. I don’t ... that moment. ”Eric suffered a massive head injury. "My pain just ...
... that men who are angry or hostile should find a ... from an irregular // heart rhythm called atrial fibrillation. Atrial ... quiver instead of beating effectively. This can cause blood to ... Researchers say this is the first study to show these ...
... acid helps women reduce their risk of birth defects. ... stroke patients alive.// Researchers say about 31,000 stroke-related deaths ... prevented each year since fortification was implemented. ,Folic ... are at an increased risk for stroke and heart ...
... recent study, researchers say , 20 minutes on an exercise ... // than even minimally invasive procedures used to open blocked ... artery disease were randomized to either the daily exercise program ... angioplasty procedure where a tiny, flexible tube (stent) is used ...
... pills do not reduce the risk of heart disease and ... ,Researchers say their results show estrogen alone does not appear ... combination hormone therapy is believed to do. Estrogen also does ... cancer. Researchers say the hormone does appear to decrease the ...
... the most common cancer in men between ages 15 and ... simply to remove it. But the way it's removed, which ... man's life. About 3 percent of all men who have ... other. If both testicles are removed, they will have no ...
Cached Medicine News:
(Date:9/2/2014)... , September 2, 2014 ... by Transparency Market Research "Latin America Home Healthcare ... Therapeutic Home Healthcare Devices, Mobility Assist Devices and ... Respiratory Therapy, Infusion Therapy and Unskilled Home Healthcare ... and Forecast, 2014 - 2020" the Latin American ...
(Date:9/2/2014)... , Spanien, September 2, 2014 /PRNewswire/ ... auf dem ESC-Kongress 2014 präsentierte GARFIELD-AF-Register ... und Behandlungsergebnisse von schlaganfallgefährdeten Patienten in ... Die Daten der ... einer innovativen und unabhängigen Forschungsinitiative zur ...
(Date:9/2/2014)... 2, 2014 Particle Sciences, the leading CDMO ... in development and manufacturing capabilities with the addition of ... , Particle Sciences, Associate Director Clinical Production, "The company ... room square footage, equipment and staff across the board, ... now has over 6000ft 2 of operating cleanroom ...
Breaking Medicine Technology:Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 2Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 3Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 4Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 5Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 6Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 2Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 3Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 4Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 5Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 6Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 7Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 8Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 9Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 10Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 11Particle Sciences Expands Drug Eluting Device Capabilities and Overall Clinical Trial Manufacturing Resources 2
... 14, 2011 The National Organization for Rare Disorders ... the U.S. Conference on Rare Diseases and Orphan Products ... in rare diseases or orphan products is invited. ... conference will be truly unique in that it will ...
... Pharmaceuticals, Inc. (NASDAQ: IDIX ), announced today that ... Global Life Sciences Conference on September 21, 2011 at 2:00 ... The live and archived webcast of the ... the Idenix Investor Center at www.idenix.com . Please log ...
Cached Medicine Technology:NORD and DIA to Host Conference on Rare Diseases and Orphan Products 2
The True Non-Compliant Balloon....
... Jude Medical® Pacing System Analyzer (PSA Wand), ... implantation testing, programming and interrogation of bradycardia ... easy-to-use accessory to the St. Jude Medical ... obtaining measurements of intrinsic P- and R-wave ...
... The Finnpipette BioControl multichannel ... features as the single ... handle fits all seven ... channel tip cone modules. ...
... Long series in colonies, rows, and microplatesthat ... the multichannel pipette is becoming an ever-increasing ... use) was the main reason that the ... 8- or 12-channel pipette provides effective, precise, ...
Medicine Products: